Bizar likita zuwa Indiya don marasa lafiya daga Angola

visa likita zuwa Indiya
Duba cikakkun bayanai kan yadda ake samun takardar izinin likita zuwa Indiya daga Angola? Visa na likita zuwa Indiya ga marasa lafiya daga Luanda, Angola. Marasa lafiya masu tafiya zuwa Indiya don haɗi tare da +91 96 1588 1588 don cikakkun bayanai & tsarin mvisa.

Share Wannan Wallafa

Duba cikakkun bayanai game da a Visa na likita zuwa Indiya daga Angola.

  • Faxar Cancer yana taimakawa wajen samun takardar izinin likita don magani. Ana ba da biza har zuwa shekara guda tare da shigarwa sau uku, muddin ana buƙatar rajista bayan mai haƙuri ya isa ƙasar.
  • Idan mutum ya nemi magani a manyan asibitoci na musamman / sanannun asibitoci a Indiya.
  • Har zuwa masu aiki biyu zasu iya raka mai haƙuri waɗanda ke da kusanci da shi / ta ƙarƙashin biza mai bi na daban waɗanda ingancin bizarsu zai kasance daidai da visa na likita

Mummunan cututtuka kamar neurosurgery; cututtukan ido; matsalolin zuciya; cututtukan koda; dashen gabobi; cututtuka na haihuwa; maganin kwayoyin halitta; maganin rediyo; filastik tiyata; maye gurbin haɗin gwiwa, da dai sauransu za su kasance na farko la'akari.

Visa na likita zuwa Indiya don Angola

Don Visa Likita, wasiƙar da aka sa hannu a asali daga asibiti / likita na gida da kuma kwafin rikodin magani ya kamata a gabatar tare da wasiƙa daga asibitin Indiya / likita a asali yana nuna cikakkun bayanai game da maganin da aka gabatar. Ga mutanen da ke bin shaidar mai nema game da dangantaka da mai haƙuri kuma ana buƙatar wasiƙa daga mai nema.

Cikakkun bayanai game da e-Visa:
e-Visa shine 60 rana wanda ba za a iya miƙa shi ba, ba mai iya canzawa ba, bizar shigar Indiya sau biyu.
The dukkan tsari na e-Visa (aikace-aikace, biyan kuɗi da karɓar biza) shine online.

Ofishin Jakadancin Indiya a Luanda ba ya taka rawa a cikin tsarin e-Visa.
 Takardar da ake buƙata don likitancin e-visa

  1. Scanned Bio Page na fasfo din da ke nuna Hotuna da Bayani
  2. Kwafin Harafi daga Asibitin da abin ya shafa a Indiya akan wasikar sa

Hoton dijital da za a ɗora tare da aikace-aikacen Visa ya kamata ya cika ƙa'idodin masu zuwa:

  1. Tsarin - JPEG
  2. size
    1. Mafi qarancin 10 KB
    2. Matsakaicin 1 MB
  3. Tsayi da faɗin Hoto dole su zama daidai.
  4. Ya kamata hoto ya gabatar da cikakkiyar fuska, gaban gani, buɗe idanu ba tare da tabarau ba.
  5. Shugaban tsakiya a cikin sifa da gabatar da cikakken kai daga saman gashi zuwa ƙasan chin
  6. Bayan fage ya zama mai haske mai haske ko fari.
  7. Babu inuwa a fuska ko a bango.
  8. Ba tare da kan iyaka ba.
  9. Scanned Bio Page na fasfo din da ke nuna Hotuna da Bayani.
    1. Tsarin -PDF
    2. Girma: Mafi qarancin 10 KB, Matsakaicin 300 KB
  10. Sauran takaddun don Kasuwancin / Manufar Likita
    1. Tsarin -PDF
    2. Girma: Mafi qarancin 10 KB, Matsakaicin 300 KB

An ba mahaɗin don takardar izinin visa a ƙasa
https://indianvisaonline.gov.in/evisa
Kar ka dogara da kowane gidan yanar gizo

Kudin Kula da Visa Likitancin Indiya

An ba da takardar izinin likita don watanni 6 tare da shigar sau uku daga Angola zuwa Indiya. Kusan yakai 14760 Angolan Kwanza (89 USD).

Lokacin Gudanar da Visa Likitancin Indiya

Za a ba da bizar likitancin Indiya daga Angola a ranar da aka gabatar da aikace-aikacen.
Bayanin Saduwa da Awanni na Aikin Babban Kwamitin Indiya a Angola

  • Ambasada: Sushil Kumar Singhal
  • Sakatare Na Farko (Consular): consular.luanda@mea.gov.in
  • Janar Tambayoyi: 222 038019, 931 521 458
  • Ayyuka na Consular: hoc.luanda@mea.gov.in
  • Ofishin Jakadancin Aiki Awanni: Awanni 0830 - awowi 1700 (Litinin zuwa Juma'a)
  • Karatun Aiki na Consular: Awanni 0900 - awowi 1200 (Litinin zuwa Juma'a)

Biyan kuɗi zuwa ga Newsletter

Sami sabuntawa kuma kada ku rasa bulogi daga Cancerfax

Toarin Don Bincika

Alectinib has been approved by the USFDA as adjuvant treatment for ALK-positive non-small cell lung cancer
Ciwon daji na huhu

Alectinib has been approved by the USFDA as adjuvant treatment for ALK-positive non-small cell lung cancer

The FDA’s recent approval of alectinib marks a significant advancement in the treatment landscape for ALK-positive non-small cell lung cancer (NSCLC). As an adjuvant therapy, alectinib offers renewed hope for patients post-surgery, targeting residual cancer cells and reducing the risk of recurrence. This milestone underscores the importance of tailored therapies in improving outcomes for patients with specific genetic mutations, ushering in a new era of precision medicine in oncology.

Ana buƙatar taimako? Ourungiyarmu a shirye take don taimaka muku.

Muna fatan samun lafiya cikin sauri na masoyinku da na kusa.

Fara hira
Muna Kan layi! Yi Taɗi da Mu!
Duba lambar
Hello,

Barka da zuwa CancerFax!

CancerFax wani dandali ne na majagaba wanda aka keɓe don haɗa mutane da ke fuskantar ciwon daji na zamani tare da hanyoyin kwantar da hankali kamar CAR T-Cell far, TIL far, da gwaji na asibiti a duk duniya.

Bari mu san abin da za mu iya yi muku.

1) Maganin ciwon daji a kasashen waje?
2) CAR T-Cell far
3) rigakafin cutar daji
4) Shawarar bidiyo ta kan layi
5) Maganin Proton